References
1. Chow EJ, Anderson L, Baker KS, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children’s Oncology Group report. Biology of Blood and Marrow Transplantation. 2016;22(5):782-795.
2. Yen H-J, Eissa H, Bhatt NS, et al. Patient-Reported Outcomes in Survivors of Childhood Hematologic Malignancies with Hematopoietic Stem Cell Transplant. Blood Journal. 2020:blood. 2019003858.
3. Buchbinder D, Kelly DL, Duarte RF, et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone marrow transplantation. 2018;53(5):535-555.
4. Kadan-Lottick NS, Zeltzer LK, Liu Q, et al. Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers. JNCI: Journal of the National Cancer Institute.2010;102(12):881-893.
5. Ellenberg L, Liu Q, Gioia G, et al. Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology. 2009;23(6):705.
6. Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR. Neurocognitive outcomes and interventions in long-term survivors of childhood cancer. Journal of Clinical Oncology. 2018;36(21):2181.
7. Iyer NS, Balsamo LM, Bracken MB, Kadan-Lottick NS. Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis. Blood.2015;126(3):346-353.
8. Brinkman TM, Krasin MJ, Liu W, et al. Long-term neurocognitive functioning and social attainment in adult survivors of pediatric CNS tumors: results from the St Jude Lifetime Cohort Study. Journal of Clinical Oncology. 2016;34(12):1358.
9. Krull KR, Annett RD, Pan Z, et al. Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. European Journal of Cancer. 2011;47(9):1380-1388.
10. Barrera M, Atenafu E. Cognitive, educational, psychosocial adjustment and quality of life of children who survive hematopoietic SCT and their siblings. Bone marrow transplantation.2008;42(1):15-21.
11. Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van den Bent MJ. Cognitive functioning and quality of life in long‐term adult survivors of bone marrow transplantation. Cancer.2002;95(1):183-192.
12. Phipps S, Rai SN, Leung W-H, Lensing S, Dunavant M. Cognitive and academic consequences of stem-cell transplantation in children.Journal of clinical oncology. 2008;26(12):2027-2033.
13. Syrjala KL, Artherholt SB, Kurland BF, et al. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. Journal of clinical oncology. 2011;29(17):2397.
14. Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK. NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biology of Blood and Marrow Transplantation. 2012;18(2):162-171.
15. Kelly DL, Buchbinder D, Duarte RF, et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 2018;24(2):228-241.
16. Baker KS, Bhatia S, Bunin N, et al. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions. Biology of Blood and Marrow Transplantation. 2011;17(10):1424-1427.
17. Lee SJ, Onstad L, Chow EJ, et al. Patient-reported outcomes and health status associated with chronic graft-versus-host disease.haematologica. 2018;103(9):1535-1541.
18. Khera N, Chow EJ, Leisenring WM, et al. Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. Biology of blood and marrow transplantation. 2011;17(7):995-1003.
19. Kenzik KM, Huang I, Brinkman TM, et al. The Childhood Cancer Survivor Study–Neurocognitive Questionnaire (CCSS-NCQ) Revised: Item response analysis and concurrent validity. Neuropsychology.2015;29(1):31.
20. Krull KR, Gioia G, Ness KK, et al. Reliability and validity of the childhood cancer survivor study neurocognitive questionnaire.Cancer. 2008;113(8):2188-2197.
21. National Institute of Neurological Disorders and Stroke (NINDS).User Manual for the Quality of Life in Neurological Disorders (Neuro-QoL) Measures, Version 2.0. 2015.
22. Yu L, Buysse DJ, Germain A, et al. Development of short forms from the PROMIS™ sleep disturbance and sleep-related impairment item banks.Behavioral sleep medicine. 2012;10(1):6-24.
23. National Health and Nutrition Examination Survey. Audiometry. https://wwwn.cdc.gov/nchs/data/nhanes/2011-2012/questionnaires/auq.pdf. Published 2011. Accessed 06/01/2020.
24. Gabel N, Altshuler DB, Brezzell A, et al. Health related quality of life in adult low and high-grade glioma patients using the national institutes of health patient reported outcomes measurement information system (PROMIS) and neuro-QOL assessments. Frontiers in neurology. 2019;10:212.
25. Cheung YT, Brinkman TM, Li C, et al. Chronic health conditions and neurocognitive function in aging survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JNCI: Journal of the National Cancer Institute. 2018;110(4):411-419.
26. Willard VW, Leung W, Huang Q, Zhang H, Phipps S. Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation. Journal of Clinical Oncology. 2014;32(35):3982.
27. Armstrong GT, Jain N, Liu W, et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies. Neuro-oncology. 2010;12(11):1173-1186.
28. Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. JNCI: Journal of the National Cancer Institute. 2009;101(13):946-958.
29. Krull KR, Zhang N, Santucci A, et al. Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. Blood, The Journal of the American Society of Hematology. 2013;122(4):550-553.
30. Mueller S, Kline CN, Buerki RA, et al. Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study.Cancer. 2020;126(5):1051-1059.
31. Clanton NR, Klosky JL, Li C, et al. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer.2011;117(11):2559-2568.
32. Mulrooney DA, Ness KK, Neglia JP, et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep.2008;31(2):271-281.
33. Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers. .Children’s Oncology Group;2018.